Page 53 - JCTR-11-5
P. 53

Journal of Clinical and
            Translational Research                                           Vaginal microbiota in menopause pathologies



            54.  Pearce M, Zilliox M, Rosenfeld AB, et al. The female urinary   of HPV epidemiology, genomics and mechanistic studies of
               microbiome in urgency urinary incontinence. Am J Obstet   HPV-mediated carcinogenesis. Viruses. 2018;10(2):80.
               Gynecol. 2015;213:347.e1-11.
                                                                  doi: 10.3390/v10020080
               doi: 10.1016/j.ajog.2015.07.009
                                                               66.  Siegel RL, Fedewa SA, Miller KD, et al. Cancer statistics for
            55.  Yu Y, Ma M, Zhou Q. The relationship between vaginal   hispanics/latinos, 2015. CA Cancer J Clin. 2015;65:457-480.
               microenvironment and pelvic dysfunctional diseases in      doi: 10.3322/caac.21314
               Chinese women: A systematic review and meta-analysis. Int
               Urogynecol J. 2023;34(12):2849-2858.            67.  Mirkovic J, Howitt BE, Roncarati P,  et al. Carcinogenic
                                                                  HPV infection in the cervical squamo-columnar junction.
               doi: 10.1007/s00192-023-05635-w
                                                                  J Pathol. 2015;236:265-271.
            56.  Łaniewski P, Ilhan ZE, Herbst-Kralovetz MM. The      doi: 10.1002/path.4533
               microbiome and gynaecological cancer development,
               prevention and therapy. Nat Rev Urol. 2020;17(4):232-250.  68.  Yim EK, Park JS. The role of HPV E6 and E7 oncoproteins in
                                                                  HPV-associated  cervical  carcinogenesis.  Cancer Res Treat.
               doi: 10.1038/s41585-020-0286-z
                                                                  2005;37:319-324.
            57.  Khan AA, Sirsat AT, Singh H, Cash P. Microbiota and cancer:
               Current understanding and mechanistic implications. Clin      doi: 10.4143/crt.2005.37.6.319
               Transl Oncol. 2022;24:193-202.                  69.  Mitra A, MacIntyre DA, Marchesi JR, Lee YS, Bennett PR,
                                                                  Kyrgiou M. The vaginal microbiota, human papillomavirus
               doi: 10.1007/s12094-021-02690-x
                                                                  infection and cervical intraepithelial neoplasia: What do we
            58.  Francescone R, Hou V, Grivennikov SI. Microbiome,   know and where are we going next? Microbiome. 2016;4:58.
               inflammation, and cancer. Cancer J. 2014;20:181-189.
                                                                  doi: 10.1186/s40168-016-0203-0
               doi: 10.1097/PPO.0000000000000048
                                                               70.  Prozialeck WC, Fay MJ, Lamar PC, Pearson CA, Sigar I,
            59.  Zhao LY, Mei JX, Yu G, et al. Role of the gut microbiota in   Ramsey  KH.  Chlamydia trachomatis disrupts  N-cadherin-
               anticancer therapy: From molecular mechanisms to clinical   dependent cell-cell junctions and sequesters beta-catenin in
               applications. Signal Transduct Target Ther. 2023;13;8(1):201.  human cervical epithelial cells. Infect Immun. 2002;70:2605-2613.
               doi: 10.1038/s41392-023-01406-7                    doi: 10.1128/IAI.70.5.2605-2613.2002
            60.  Loo TM, Kamachi F,Watanabe Y,  et al. Gut microbiota   71.  Oh HY, Kim BS, Seo SS, et al. The association of uterine
               promotes obesity-associated liver cancer through PGE -  cervical microbiota with an increased risk for cervical
                                                         2
               mediated suppression of antitumor immunity.  Cancer   intraepithelial neoplasia in Korea.  Clin  Microbiol  Infect.
               Discov. 2017;7:522-538.                            2015;21:674.e1-9.
               doi: 10.1158/2159-8290.CD-16-0932                  doi: 10.1016/j.cmi.2015.02.026
            61.  Uemura N, Okamoto S,Yamamoto S,  et al.  Helicobacter   72.  Gao W, Weng J, Gao Y, Chen X. Comparison of the vaginal
               pylori infection and the development of gastric cancer.   microbiota diversity of women with and without human
               N Engl J Med. 2001;345:784-789.                    papillomavirus infection: A  cross-sectional study.  BMC
               doi: 10.1056/NEJMoa001999                          Infect Dis. 2013;13:271.
            62.  Wang N, Fang JY. Fusobacterium nucleatum, a key pathogenic      doi: 10.1186/1471-2334-13-271
               factor and microbial biomarker for colorectal cancer. Trends   73.  Lee  JE,  Lee  S,  Lee  H,  et al.  Association of  the  vaginal
               Microbiol. 2023;31:159-172.                        microbiota  with  human papillomavirus infection in  a
               doi: 10.1016/j.tim.2022.08.010                     Korean twin cohort. PLoS One. 2013;8(5):e63514.
            63.  Zadora PK, Chumduri C, Imami K,  et al. Integrated      doi: 10.1371/journal.pone.0063514
               phosphoproteome and transcriptome analysis reveals   74.  Di Paola M, Sani C, Clemente AM, et al. Characterization
               chlamydia-induced epithelial-to-mesenchymal transition in   of  cervico-vaginal  microbiota  in  women  developing
               host cells. Cell Rep. 2019;26:1286-1302.e8.        persistent  high-risk  human  papillomavirus  infection.  Sci
               doi: 10.1016/j.celrep.2019.01.006                  Rep. 2017;7:10200.
            64.  Takada K, Melnikov VG, Kobayashi R, Komine-Aizawa S,      doi: 10.1038/s41598-017-09842-6
               Tsuji NM, Hayakawa S. Female reproductive tract-organ   75.  Doll KM, Snyder CR, Ford CL. Endometrial cancer
               axes. Front Immunol. 2023;14:1110001.              disparities: A race-conscious critique of the literature. Am J
               doi: 10.3389/fimmu.2023.1110001                    Obstet Gynecol. 2018;218:474-482.e2.
            65.  Mirabello L, Clarke MA, Nelson CW, et al. The intersection      doi: 10.1016/j.ajog.2017.09.016


            Volume 11 Issue 5 (2025)                        47                         doi: 10.36922/JCTR025150016
   48   49   50   51   52   53   54   55   56   57   58